05Mar
Blood soluble OX40 (CD134) levels in advanced colorectal cancer
Last updated: 02nd February, 2022
Products are for professional/laboratory use only.
A recent publication in the oncology field revealed that high blood levels of soluble OX40 indicate reduced survival in patients with advanced colorectal cancer (CRC).
The study published in Oncology Reports utilised the IBL Human CD134/OX40 ELISA Assay in the investigation of 22 patients with advanced CRC.
Ordering information:
Product Code: IB30168993
Description: CD135/OX40 ELISA